AIFA	Italian Medicines Agency (Agenzia Italiana del Farmaco)
DALY	Disability-Adjusted Life Years
GRADE	Grading of Recommendations Assessment, Development, and Evaluation
HRQOL	Health-Related Quality of Life
HTA	Health Technology Assessment
ICER	Incremental Cost–Effectiveness Ratio
NDA	New Drug Approval
NME	New Molecular Entity
PRIME	PRIority MEdicines
P&R	Price and Reimbursement
PRO(M)s	Patient-Reported Outcome (Measure)s
QALY	Quality-Adjusted Life Years
RCT	Randomized Control Trial